{
    "nctId": "NCT03348696",
    "briefTitle": "Comparing Tapering Low Dose Dexamethasone to Other Standard of Care Therapies for TAPS in Breast Cancer Patients",
    "officialTitle": "A Multi-Centre Randomised Study Comparing Tapering Low Dose Dexamethasone to Other Standard of Care Therapies for Taxane- Associated Pain Syndrome (TAPS) in Breast Cancer Patients (OTT 17-02 REaCT-TAPS)",
    "overallStatus": "COMPLETED",
    "conditions": "Early-stage Breast Cancer, Pain Syndrome",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE4",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 124,
    "primaryOutcomeMeasure": "Evaluation of TAPS",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients receiving docetaxel-based chemotherapy (Docetaxel 75mg/m2 and cyclophosphamide once every 21 days; or Docetaxel 75mg/m2 and carboplatin and trastuzumab once every 21 days or Fluoro-uracil, epirubicin and cyclophosphamide for 3 cycles once every 21 days, then docetaxel 100mg/m2 once every 21 days; or Adriamycin and cyclophosphamide for 3 cycles, then docetaxel 100mg/m2 once every 21 days) for early stage breast cancer.\n\n  * English literacy and ability to complete questionnaire\n  * \u226519 years of age\n\nExclusion Criteria:\n\n* Contraindication to dexamethasone\n* Unable to give informed consent\n* Prior receipt of taxane-based chemotherapy\n* Patient has a significant emotional or psychiatric disorder that in the opinion of the investigator precludes study entry.",
    "sex": "ALL",
    "minimumAge": "19 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}